Table 3. Subgroup analysis by IBD type .

	IBD type			p value
	CD	UC	Total	Switched therapy, n (%)
Primary non-responder to Anti-TNF blocking agents	16.3%	15.8%	16.05%	NS
Secondary loss of response to Anti-TNF blocking agents	15.6%	18.3%	16.9%	NS
Responder to Anti-TNF blocking agents	68.1%	65.9%	67%	NS